The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of B7-H3 targeting CAR-T cell therapy for patients with recurrent GBM.
 
Yang Zhang
No Relationships to Disclose
 
Rui Feng
Employment - Fuzhou tcelltech
 
Xiaohan Chi
No Relationships to Disclose
 
Na Xian
Employment - Fuzhou Tcelltech
 
Xianzhen Chen
Employment - Fuzhou Tcelltech
 
Na Huang
No Relationships to Disclose
 
Yu Zhang
No Relationships to Disclose
 
Kangna Zhang
No Relationships to Disclose
 
Jindong Zhang
Employment - Fuzhou Tcelltech
 
Lieping Chen
Leadership - Junshi Biosciences
Stock and Other Ownership Interests - Drimmunity; NextCure; Normunity; OncoC4; TAYU Biotech; Zai Lab
Consulting or Advisory Role - Drimmunity; NextCure; OncoC4; Zai Lab
Research Funding - NextCure; Normunity; TAYU Biotech
Patents, Royalties, Other Intellectual Property - NextCure; Normunity
(OPTIONAL) Uncompensated Relationships - Normunity
 
Nan Ji
No Relationships to Disclose
 
Gangxiong Huang
Employment - Fuzhou Tcelltech
Leadership - Drimmunity; Fuzhou Tcelltech
Stock and Other Ownership Interests - Drimmunity
Patents, Royalties, Other Intellectual Property - Fuzhou Tcelltech